---
schema_version: "secwatch.filing_event.v1"
accession: "0001513162-22-000147"
form_type: "8-K"
ticker: "BMRA"
cik: "0000073290"
company_name: "BIOMERICA INC"
filed_at: "2022-12-16T23:59:59+00:00"
generated_at: "2026-06-21T03:47:38.812913+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Biomerica CFO Steve Sloan resigns; stays interim while search underway

## Summary
- CFO Steve Sloan notified resignation on Dec 12, 2022 to pursue new career opportunity.
- Sloan will serve as interim CFO while company conducts a search for a permanent replacement.
- Vice Chairman Allen Barbieri will assist financial and accounting departments until new CFO is appointed.

## SEC filing metadata
- accession: 0001513162-22-000147
- form_type: 8-K
- ticker: BMRA
- cik: 0000073290
- company_name: BIOMERICA INC
- filed_at: 2022-12-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/73290/000151316222000147/0001513162-22-000147-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/73290/000151316222000147/bmra-20221212.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001513162-22-000147
- JSON: https://secwatch.observer/filing/0001513162-22-000147.json
- Plain text: https://secwatch.observer/filing/0001513162-22-000147.txt

## Key facts
- Executive change
  Steve Sloan changed role as Chief Financial Officer at BIOMERICA INC.
  - Action: stepping down
  - Role: Chief Financial Officer
  source text: On December 12, 2022, Steve Sloan notified Biomerica Inc. (the “Company”) that he will be stepping down from his position as Chief Financial Officer (“CFO”) of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/73290/000151316222000147/0001513162-22-000147-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.